ASKLEPIOS BIOPHARMACEUTICAL, INC.

Address

45 North Chatham Parkway
CHAPEL HILL, NC, 27517-6040

Information

DUNS: 604014345
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease

    Amount: $270,008.00

    Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International' ...

    STTRPhase I2014Department of Health and Human Services
  2. Preclinical Development of AAV-Galanin for Epilepsy

    Amount: $282,210.00

    DESCRIPTION (provided by applicant): This proposal seeks to leverage proprietary technical advances in Adeno-Associated Virus (AAV) vector mediated gene therapy to develop an AAV based Galanin gene de ...

    SBIRPhase I2008Department of Health and Human Services
  3. Preclinical Studies Supporting Phase Ib Study of Minidystrophin Gene in AAV Vecto

    Amount: $2,694,020.00

    DESCRIPTION (provided by applicant): This proposal intends to advance the regional delivery of a chimeric adeno-associated virus (rAAV)-based, highly-truncated dystrophin (minidystrophin) gene therapy ...

    SBIRPhase I2008Department of Health and Human Services
  4. rAAV Revitalized Structural Allografts

    Amount: $157,070.00

    DESCRIPTION (provided by applicant): Repair of large structural bone defects remains a major problem in orthopaedic reconstruction surgery due to the limited supply of cortical bone autograft and the ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government